Ribonucleic Acid News and Research

RSS

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

Researchers estimated the probability of SARS-CoV-2 reinfection following COVID-19 recovery. Additionally, they determined the effectiveness of the primary vaccination series in reducing the reinfection risk.

29 Jul 2022

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Researchers estimated the impact of different COVID-19 mRNA booster vaccinations in the United States during fall 2022.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Researchers describe the evolution of the SARS-CoV-2 non-structural protein 1 (NSP1).

28 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

COVID-19 Moderna vaccine induces significant antibody reactions among children

Researchers illustrated that SARS-CoV-2 messenger ribonucleic acid vaccination triggers potent antibody reactions in children.

28 Jul 2022

Researchers find adeno-associated virus 2 infection in children with hepatitis of unknown etiology

Researchers investigated the cases of severe hepatitis of unknown etiology in young children who presented to the hospital between 14 March and 4 April 2022 in Scotland.

28 Jul 2022

Researchers present a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants

Researchers presented a novel genomic sequence data-based mathematical framework for rapid detection of SARS-CoV-2 variants of interest and variants of concern in a viral multiple sequence alignment.

28 Jul 2022

Icelandic study reveals how many children experience severe COVID symptoms

Researchers explore the incidence of SARS-CoV-2 infections in Icelandic children.

27 Jul 2022

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Researchers evaluate the effectiveness of mRNA COVID-19 vaccines among patients receiving CAR‐T‐lymphocyte therapy.

27 Jul 2022

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Researchers evaluate the neutralizing potency of therapeutic monoclonal antibodies against three sub-lineages of the SARS-CoV-2 Omicron variant.

27 Jul 2022

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Researchers evaluate antibody titers after double COVID-19 vaccination among very elderly individuals over the age of 90 and a younger population.

27 Jul 2022

The nose key to winning the war against COVID-19

researchers assess the respiratory mucosal immunity elicited by COVID-19 vaccination.

27 Jul 2022

Study shows SARS-CoV-2 impairs interferon production through NSP2-induced repression of mRNA translation

Researchers discovered a SARS-CoV-2 non-structural protein 2 (NSP2)-mediated mechanism by which it suppresses the production of interferon-beta (IFN-β) in host cells.

27 Jul 2022

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Researchers depicted the correlations between receptor-binding domain (RBD)-selective proliferative memory CD4 T cells and neutralizing antibodies in COVID-19 vaccinees and convalescent patients.

27 Jul 2022